Tokyo Tape
Sign in
← AuBEX

Half-year report · Q2

3583.TEDINET S100UOJ8
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥3.0bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥5.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥2.6bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥489m2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥270m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥454m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥601m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥294m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥452m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥294m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥302m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥436m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥218m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥302m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥218m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥9.6bnat 2024-09-30Cons.Assets
Total assets¥9.7bnat 2024-03-31Cons.Assets
Total assets¥9.5bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥3.1bnat 2024-09-30Cons.Liabilities
Total liabilities¥3.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥6.5bnat 2024-09-30Cons.Net assets
Net assets / equity¥6.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥6.0bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.8bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥2.5bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.4bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥313m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥601m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥202m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥165m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥99m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥391m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥451m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥139m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥108.12024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥156.82023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.212023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio67.6%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio64.4%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio63.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥817m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥817m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥513,000
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥65m
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥2.2bn
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥2.2bn
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥598m
—segment totalrevenue2024-04-01 → 2024-09-30¥3.0bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥3.0bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥513,000
—segment totalsegment profit2024-04-01 → 2024-09-30¥663m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥513,000
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥663m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥721m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥720m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥645,000
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥48m
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥1.9bn
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.9bn
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥382m
—segment totalrevenue2023-04-01 → 2023-09-30¥2.6bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥2.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥645,000
—segment totalsegment profit2023-04-01 → 2023-09-30¥430m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥645,000
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥430m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Other ioaPrior1YearInstant64793000JPY
Other ioaCurrentQuarterInstant63456000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-5993000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-5993000JPY
Investments and other assetsPrior1YearInstant285497000JPY
Investments and other assetsCurrentQuarterInstant267238000JPY
Noncurrent assetsPrior1YearInstant3378738000JPY
Noncurrent assetsCurrentQuarterInstant3304629000JPY
AssetsPrior1YearInstant9721703000JPY
AssetsCurrentQuarterInstant9625248000JPY
Notes and accounts payable tradePrior1YearInstant150491000JPY
Notes and accounts payable tradeCurrentQuarterInstant172621000JPY
Electronically recorded obligations operating clPrior1YearInstant295460000JPY
Electronically recorded obligations operating clCurrentQuarterInstant298287000JPY
Current portion of long term loans payablePrior1YearInstant695302000JPY
Current portion of long term loans payableCurrentQuarterInstant544100000JPY
Lease obligations clPrior1YearInstant14348000JPY
Lease obligations clCurrentQuarterInstant13002000JPY
Income taxes payablePrior1YearInstant113164000JPY
Income taxes payableCurrentQuarterInstant134386000JPY
Provision for bonusesPrior1YearInstant105399000JPY
Provision for bonusesCurrentQuarterInstant136063000JPY
Other clPrior1YearInstant374074000JPY
Other clCurrentQuarterInstant271571000JPY
Current liabilitiesPrior1YearInstant1748240000JPY
Current liabilitiesCurrentQuarterInstant1570032000JPY
Long term loans payablePrior1YearInstant1091600000JPY
Long term loans payableCurrentQuarterInstant920270000JPY
Lease obligations nclPrior1YearInstant38479000JPY
Lease obligations nclCurrentQuarterInstant32426000JPY
Deferred tax liabilities for land revaluationPrior1YearInstant23042000JPY
Deferred tax liabilities for land revaluationCurrentQuarterInstant23042000JPY
Provision for share based remuneration nclPrior1YearInstant164857000JPY
Provision for share based remuneration nclCurrentQuarterInstant156679000JPY
Net defined benefit liabilityPrior1YearInstant398322000JPY
Net defined benefit liabilityCurrentQuarterInstant412973000JPY
Other nclPrior1YearInstant515000JPY
Other nclCurrentQuarterInstant515000JPY
Noncurrent liabilitiesPrior1YearInstant1716816000JPY
Noncurrent liabilitiesCurrentQuarterInstant1545907000JPY
LiabilitiesPrior1YearInstant3465057000JPY
LiabilitiesCurrentQuarterInstant3115939000JPY
Capital stockPrior1YearInstant1939834000JPY
Capital stockCurrentQuarterInstant1939834000JPY
Capital surplusPrior1YearInstant518489000JPY
Capital surplusCurrentQuarterInstant518489000JPY
Retained earningsPrior1YearInstant3810166000JPY
Retained earningsCurrentQuarterInstant4050904000JPY
Treasury stockPrior1YearInstant-201060000JPY
Treasury stockCurrentQuarterInstant-179358000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass